Neurocrine Bioscience buy Morgan Stanley

Summary

This prediction ended on 13.07.25 with a price of €113.10. The price of Neurocrine Bioscience has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.17%. Morgan_Stanley has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Neurocrine Bioscience	-1.771%	-1.771%	10.784%
iShares Core DAX®	-2,53 %	-5,19 %	4,91 %
iShares Nasdaq 100	-0,03 %	1,56 %	21,79 %
iShares Nikkei 225®	-4,20 %	-7,55 %	31,13 %
iShares S&P 500	-0,80 %	0,16 %	15,78 %